日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4.

RPL22 是 MSI 高表达癌症中的肿瘤抑制因子,也是 MDM4 的剪接调节因子

Weinstein Hannah N W, Hu Kevin, Fish Lisa, Chen Yih-An, Allegakoen Paul, Pham Julia H, Hui Keliana S F, Chang Chih-Hao, Tutar Meltem, Benitez-Rivera Lorena, Baco Maria B, Song Hanbing, Giacomelli Andrew O, Vazquez Francisca, Ghandi Mahmoud, Goodarzi Hani, Huang Franklin W

Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer

基因组筛选发现抗凋亡基因是卵巢癌化疗耐药性的可靶向介质

Stover, Elizabeth H; Baco, Maria B; Cohen, Ofir; Li, Yvonne Y; Christie, Elizabeth L; Bagul, Mukta; Goodale, Amy; Lee, Yenarae; Pantel, Sasha; Rees, Matthew G; Wei, Guo; Presser, Adam G; Gelbard, Maya K; Zhang, Weiqun; Zervantonakis, Ioannis K; Bhola, Patrick D; Ryan, Jeremy; Guerriero, Jennifer L; Montero, Joan; Liang, Felice J; Cherniack, Andrew D; Piccioni, Federica; Matulonis, Ursula A; Bowtell, David D L; Sarosiek, Kristopher A; Letai, Anthony; Garraway, Levi A; Johannessen, Cory M; Meyerson, Matthew